Lombard Odier Asset Management (Europe)’s AstraZeneca AZN Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,136	Closed	-$1.78M	–	274
2024 Q1	$1.78M	Sell	13,136 -18	-0.1%	-$2.38K	0.11%	167
2023 Q4	$1.77M	Buy	13,154 +40	+0.3%	+$5.2K	0.1%	171
2023 Q3	$1.78M	Sell	13,114 -32	-0.2%	-$4.37K	0.09%	187
2023 Q2	$1.88M	Sell	13,146 -534	-4%	-$78.6K	0.09%	191
2023 Q1	$1.9M	Sell	13,680 -1,244	-8%	-$167K	0.09%	195
2022 Q4	$2.02M	Sell	14,924 -610	-4%	-$76.5K	0.08%	201
2022 Q3	$1.7M	Sell	15,534 -1,731	-10%	-$220K	0.09%	183
2022 Q2	$2.28M	Buy	+17,265	New	+$2.27M	0.11%	167

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s AZN Position: Q2 2024 in Review

Lombard Odier Asset Management (Europe) sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 13,136 shares — an estimated $1.78M sold.

Lombard Odier Asset Management (Europe) first reported a position in AZN in Q2 2022 and held it in 8 quarters. The position peaked at $2.28M in Q2 2022. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

Lombard Odier Asset Management (Europe) reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 13,136 AstraZeneca shares in Q2 2024, an estimated $1.78M.
Lombard Odier Asset Management (Europe) first reported a position in AstraZeneca in Q2 2022 and held it in 8 quarters.
Lombard Odier Asset Management (Europe)'s AstraZeneca position peaked at $2.28M in Q2 2022.
1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2024, filed 14 Aug 2024.